arrow
C

Cynthia Villarreal-Garza

Tecnologico de Monterrey
H指数:42
被引数:6,582

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunohistochemistry-based molecular subtypes and stromal tumor-infiltrating lymphocytes in triple-negative breast cancer: a chemotherapy-only cohort

基于免疫组化分型的三阴性乳腺癌分子亚型及间质肿瘤浸润淋巴细胞:一项仅化疗队列研究

2026-08-120
OAAI
TroFuse-011 study design: sacituzumab tirumotecan with or without pembrolizumab for advanced triple-negative breast cancer with PD-L1 CPS <10

TroFuse-011研究设计:sacituzumab tirumotecan联合或不联合pembrolizumab治疗PD-L1 CPS<10的晚期三阴性乳腺癌

2026-07-310
OA
Clinical characteristics and survival outcomes of young women with luminal HER2-low and HER2-ultralow breast cancer (vol 46, 101112, 2026)

年轻女性中,luminal HER2-low和HER2-ultralow乳腺癌的临床特征与生存结局(卷46,101112,2026)

2026-05-010
PRE
Five-year longitudinal changes in social, economic, and psychosocial wellbeing among young women with breast cancer in Mexico

墨西哥乳腺癌年轻女性在社会、经济及心理社会福祉方面的五年纵向变化

2026-04-230
PRE
Prospective patient navigation program for young women with breast cancer: assessment and referrals to address medical and supportive care needs

针对年轻乳腺癌女性的前瞻性患者导航计划: 评估和转诊以满足医疗和支持性护理需求

2026-01-010
PRE
ASSOCIATION BETWEEN TYPE AND LOCATION OF GERMLINE BRCA1/2 PATHOGENIC OR LIKELY PATHOGENIC VARIANTS WITH PHENOTYPE AND PROGNOSIS IN YOUNG PATIENTS WITH BREAST CANCER: RESULTS FROM AN INTERNATIONAL COHORT STUDY

年轻乳腺癌患者BRCA1/2致病性或可能致病性变异的类型和位置与表型和预后之间的关系: 一项国际队列研究的结果

2025-11-170
OAAI
Physician treatment decisions for hormone receptor-positive, HER2-negative early breast cancer in young patients: a Latin American survey

年轻患者激素受体阳性、HER2阴性早期乳腺癌的医师治疗决策:一项拉丁美洲调查

2025-10-150
OA
Factors associated with accepting chemotherapy despite the risk of fertility loss in Latin American breast cancer patients—LACOG 0414 study

与拉美乳腺癌患者尽管存在生育力丧失风险仍接受化疗相关的因素—LACOG 0414研究

2025-10-020
OA
Correction: Rodríguez-Bautista et al. Immune Milieu and Genomic Alterations Set the Triple-Negative Breast Cancer Immunomodulatory Subtype Tumor Behavior. Cancers 2021, 13, 6256

更正:Rodríguez-Bautista等人。免疫微环境与基因组改变决定了三阴性乳腺癌免疫调节亚型的肿瘤行为。Cancers 2021, 13, 6256

2025-10-010
OAAI
Fertility and ovarian function preservation in young women with breast cancer: A joint analysis of the Joven & Fuerte and PREFER prospective studies

年轻乳腺癌女性患者的生育能力和卵巢功能保护:Joven & Fuerte和PREFER前瞻性研究的联合分析

2025-10-010
OAAI
Breastfeeding after breast cancer in young BRCA carriers

Blondeaux, E.; Delucchi, V.; Mariamidze, E.; Bernstein-Molho, R.; Frank, S.; Ferrari, A.; Linn, S.; Jeong Kim, H.; Agostinetto, E.; Paluch-Shimon, S.; 等. 乳腺癌后母乳喂养在年轻BRCA携带者中的应用. J. Natl. Cancer Inst. 2025, djaf177. [Google Scholar] [CrossRef] [PubMed]

2025-08-012
OAAI
National cancer control plans in Latin America and the Caribbean: challenges and future directions

拉丁美洲和加勒比地区的国家癌症控制计划:挑战与未来方向

2025-05-280
PRE
Evaluating changes in the breast cancer-related quality of life of young women with breast cancer: long-term results from a multicenter prospective cohort

评估年轻乳腺癌患者乳腺癌相关生活质量的变化:多中心前瞻性队列研究的长期结果

2025-05-160
OA
Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study

风险降低手术与年轻BRCA携带者乳腺癌患者生存期的关联:一项国际队列研究

2025-05-080
PRE